Merck's COVID drug Molnupiravir clears customs

The first batch of Molnupiravir, a COVID-19 drug developed by US pharmaceutical company Merck, finished customs clearance at Shanghai Waigaoqiao Free Trade Zone on Friday and entered the domestic market.

Related Keywords

China ,Waigaoqiao ,Shanghai ,Dai Qian ,Fujian ,Chinese , ,National Medical Products Administration ,Sinopharm Group ,Shanghai Waigaoqiao Free Trade Zone ,Waigaoqiao Free Trade Zone ,Developed ,Sb ,Pharmaceutical ,Friday ,Company ,Zone ,Merck ,Trade ,Finishes ,Free ,